Iradimed (IRMD) to Release Quarterly Earnings on Thursday

Iradimed (NASDAQ:IRMD) will be posting its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Iradimed to post earnings of $0.31 per share for the quarter. Iradimed has set its FY 2024 guidance at 1.520-1.620 EPS and its Q1 2024 guidance at 0.330-0.350 EPS.Investors that wish to register for the company’s conference call can do so using this link.

Iradimed (NASDAQ:IRMD) last posted its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). Iradimed had a net margin of 26.22% and a return on equity of 24.62%. The firm had revenue of $17.45 million for the quarter. On average, analysts expect Iradimed to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Iradimed Stock Up 0.3 %

Shares of NASDAQ:IRMD traded up $0.11 on Tuesday, hitting $41.01. 10,124 shares of the company traded hands, compared to its average volume of 50,966. Iradimed has a 52 week low of $36.12 and a 52 week high of $51.04. The stock has a 50 day simple moving average of $42.65 and a 200-day simple moving average of $43.09. The company has a market cap of $519.19 million, a PE ratio of 30.07 and a beta of 0.82.

Analysts Set New Price Targets

IRMD has been the topic of several research analyst reports. Singular Research restated a “buy” rating on shares of Iradimed in a research report on Monday, April 1st. Roth Capital reissued a “buy” rating on shares of Iradimed in a research note on Monday, April 22nd. Finally, Roth Mkm reaffirmed a “buy” rating and set a $65.00 price target on shares of Iradimed in a research note on Monday, April 22nd.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.